THERAPEUTIC PRODUCT CONTAMINATION side effect
What is THERAPEUTIC PRODUCT CONTAMINATION ?Drugs associated with THERAPEUTIC PRODUCT CONTAMINATION
ACETAMINOPHEN ACTOS ALBUTEIN BALANCED BYETTA CARDIAC CLINDAMYCIN EXTRA HEPARIN HUMATE LAMISIL MIRENA ORENCIA REMICADE ROCALTROL TRAVASOLTHERAPEUTIC PRODUCT CONTAMINATION : Orencia Side Effects Report #5612316-1
Physician from UNITED STATES reported ORENCIA problem on Feb 01, 2008. Female patient, weighting 202.8 lb, was diagnosed with rheumatoid arthritis and was treated with ORENCIA. After drug was administered, patient experienced the following problems/side effects: therapeutic product contamination, wound infection staphylococcal, . ORENCIA dosage: unknown. During the same period patient was treated with METHOTREXATE. Patient was hospitalized. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Balanced Side Effects Report #5622974-3
BALANCED SALT problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 04, 2008. Female patient, 73 years of age, was diagnosed with eye irrigation and was treated with BALANCED SALT. After drug was administered, patient experienced the following problems/side effects: therapeutic product contamination, . BALANCED SALT dosage: unknown. During the same period patient was treated with EPINEPHRINE. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Balanced Side Effects Report #5609473-X
Consumer or non-health professional from UNITED STATES reported BALANCED SALT SOLUTION problem on Jan 24, 2008. Female patient, 73 years of age, was diagnosed with eye irrigation and was treated with BALANCED SALT SOLUTION. After drug was administered, patient experienced the following problems/side effects: therapeutic product contamination, . BALANCED SALT SOLUTION dosage: unknown. During the same period patient was treated with EPINEPHRINE. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Balanced Side Effects Report #5648879-X
BALANCED SALT problem was reported by a Health Professional from UNITED STATES on Feb 20, 2008. Female patient, 73 years of age, was diagnosed with eye irrigation and was treated with BALANCED SALT. After drug was administered, patient experienced the following problems/side effects: eye inflammation, therapeutic product contamination, . BALANCED SALT dosage: unknown. During the same period patient was treated with EPINEPHRINE. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Clindamycin Side Effects Report #5657202-6
Consumer or non-health professional from UNITED STATES reported CLINDAMYCIN problem on Mar 07, 2008. Female patient, 47 years of age, weighting 200.0 lb, was diagnosed with dental operation, prophylaxis and was treated with CLINDAMYCIN. After drug was administered, patient experienced the following problems/side effects: therapeutic product contamination, urticaria, . CLINDAMYCIN dosage: unknown. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Humate Side Effects Report #5684197-1
HUMATE problem was reported by a Physician from UNITED STATES on Mar 27, 2008. Male patient, weighting 28.00 lb, was diagnosed with subdural haematoma, von willebrand's disease and was treated with HUMATE. After drug was administered, patient experienced the following problems/side effects: hepatitis c antibody positive, therapeutic product contamination, . HUMATE dosage: unknown. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Lamisil Side Effects Report #5622851-8
Consumer or non-health professional from CANADA reported LAMISIL problem on Jan 29, 2008. Male patient, 18 years of age, was diagnosed with wound infection fungal and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: superinfection, therapeutic product contamination, . LAMISIL dosage: unknown. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Lamisil Side Effects Report #5636876-X
LAMISIL problem was reported by a Consumer or non-health professional from CANADA on Feb 06, 2008. Male patient, 18 years of age, was diagnosed with wound infection fungal and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: superinfection, therapeutic product contamination, . LAMISIL dosage: unknown. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Extra Side Effects Report #5598406-0
Consumer or non-health professional from UNITED STATES reported EXTRA STRENGTH TYLENOL problem on Jan 11, 2008. Male patient was diagnosed with pain and was treated with EXTRA STRENGTH TYLENOL. After drug was administered, patient experienced the following problems/side effects: gastric disorder, therapeutic product contamination, . EXTRA STRENGTH TYLENOL dosage: unknown. During the same period patient was treated with EXTRA STRENGTH TYLENOL. Patient was hospitalized. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Acetaminophen Side Effects Report #5537343-4
ACETAMINOPHEN problem was reported by a Consumer or non-health professional from TURKEY on Nov 29, 2007. Male patient, child 2 years of age, weighting 23.15 lb, was treated with ACETAMINOPHEN. After drug was administered, patient experienced the following problems/side effects: therapeutic product contamination, . ACETAMINOPHEN dosage: 5ML PER DAY. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Travasol Side Effects Report #5555760-3
Consumer or non-health professional from UNITED STATES reported TRAVASOL problem on Dec 06, 2007. Female patient was diagnosed with nutritional support and was treated with TRAVASOL. After drug was administered, patient experienced the following problems/side effects: fungal peritonitis, therapeutic product contamination, . TRAVASOL dosage: unknown. During the same period patient was treated with PROSOL, STERILE WATERECTION IN PLASTIC CONTAINER. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Travasol Side Effects Report #5555814-1
TRAVASOL problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 06, 2007. Female patient was diagnosed with nutritional support and was treated with TRAVASOL. After drug was administered, patient experienced the following problems/side effects: peritonitis bacterial, therapeutic product contamination, . TRAVASOL dosage: unknown. During the same period patient was treated with PROSOL, STERILE WATERECTION IN PLASTIC CONTAINER. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Acetaminophen Side Effects Report #5525445-8
Consumer or non-health professional from TURKEY reported ACETAMINOPHEN problem on Nov 26, 2007. Male patient, child 2 years of age, weighting 23.15 lb, was treated with ACETAMINOPHEN. After drug was administered, patient experienced the following problems/side effects: therapeutic product contamination, . ACETAMINOPHEN dosage: 5ML PER DAY. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Mirena Side Effects Report #5412699-1
MIRENA problem was reported by a Consumer or non-health professional from CANADA on Aug 02, 2007. Female patient was treated with MIRENA. After drug was administered, patient experienced the following problems/side effects: iud migration, therapeutic product contamination, . MIRENA dosage: unknown. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Byetta Side Effects Report #5385098-9
Pharmacist from UNITED STATES reported BYETTA problem on July 05, 2007. Female patient, 36 years of age, weighting 230.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: device failure, therapeutic product contamination, . BYETTA dosage: unknown. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Actos Side Effects Report #5393006-X
ACTOS problem was reported by a Health Professional from UNITED STATES on July 05, 2007. Female patient was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: no adverse reaction, therapeutic product contamination, . ACTOS dosage: 45 MG, 1 IN 1 D, PER ORAL. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Byetta Side Effects Report #5385098-9
Pharmacist from UNITED STATES reported BYETTA problem on July 05, 2007. Female patient, 36 years of age, weighting 230.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: device failure, therapeutic product contamination, . BYETTA dosage: unknown. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Actos Side Effects Report #5393006-X
ACTOS problem was reported by a Health Professional from UNITED STATES on July 05, 2007. Female patient was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: no adverse reaction, therapeutic product contamination, . ACTOS dosage: 45 MG, 1 IN 1 D, PER ORAL. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Balanced Side Effects Report #5663431-8
Health Professional from UNITED STATES reported BALANCED SALT problem on Mar 03, 2008. Female patient, 73 years of age, was diagnosed with eye irrigation and was treated with BALANCED SALT. After drug was administered, patient experienced the following problems/side effects: eye infection fungal, eye inflammation, therapeutic product contamination, . BALANCED SALT dosage: unknown. During the same period patient was treated with EPINEPHRINE. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Lamisil Side Effects Report #5689547-8
LAMISIL problem was reported by a Pharmacist from CANADA on Mar 19, 2008. Male patient, 18 years of age, was diagnosed with wound infection fungal and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: superinfection, therapeutic product contamination, . LAMISIL dosage: unknown. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Albutein Side Effects Report #5694073-6
Pharmacist from MALAYSIA reported ALBUTEIN problem on Mar 02, 2008. Male patient, 69 years of age, weighting 143.3 lb, was diagnosed with hepatic cirrhosis and was treated with ALBUTEIN. After drug was administered, patient experienced the following problems/side effects: sepsis, stenotrophomonas infection, therapeutic product contamination, . ALBUTEIN dosage: 50 ML 2X/DAILY IV. Patient was hospitalized. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Cardiac Side Effects Report #5695384-0
CARDIAC problem was reported by a Consumer or non-health professional from CANADA on Mar 26, 2008. Female patient was treated with CARDIAC. After drug was administered, patient experienced the following problems/side effects: laboratory test interference, therapeutic product contamination, . CARDIAC dosage: unknown. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Heparin Side Effects Report #5587882-5
Consumer or non-health professional from UNITED STATES reported HEPARIN LOCK problem on Jan 09, 2008. Female patient, 40 years of age, weighting 128.0 lb, was diagnosed with intravenous catheter management and was treated with HEPARIN LOCK. After drug was administered, patient experienced the following problems/side effects: malaise, therapeutic product contamination, . HEPARIN LOCK dosage: unknown. During the same period patient was treated with HEPARIN LOCK. Patient was hospitalized. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Heparin Side Effects Report #5587971-5
HEPARIN LOCK problem was reported by a Physician from UNITED STATES on Jan 08, 2008. Female patient was treated with HEPARIN LOCK. After drug was administered, patient experienced the following problems/side effects: sepsis, therapeutic product contamination, . HEPARIN LOCK dosage: unknown. Patient was hospitalized. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Heparin Side Effects Report #5602052-X
Pharmacist from UNITED STATES reported HEPARIN problem on Jan 22, 2008. Male patient, 44 years of age, weighting 310.9 lb, was diagnosed with pulmonary embolism and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: blood culture positive, serratia infection, therapeutic product contamination, . HEPARIN dosage: unknown. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Heparin Side Effects Report #5563496-8
HEPARIN LOCK FLUSH PRESERVATIVE FREE problem was reported by a Pharmacist from UNITED STATES on Dec 14, 2007. Female patient was treated with HEPARIN LOCK FLUSH PRESERVATIVE FREE. After drug was administered, patient experienced the following problems/side effects: serratia bacteraemia, therapeutic product contamination, . HEPARIN LOCK FLUSH PRESERVATIVE FREE dosage: unknown. Patient was hospitalized. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Heparin Side Effects Report #5563497-X
Pharmacist from UNITED STATES reported HEPARIN LOCK FLUSH PRESERVATIVE FREE problem on Dec 14, 2007. Female patient was treated with HEPARIN LOCK FLUSH PRESERVATIVE FREE. After drug was administered, patient experienced the following problems/side effects: serratia bacteraemia, therapeutic product contamination, . HEPARIN LOCK FLUSH PRESERVATIVE FREE dosage: unknown. Patient was hospitalized. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Heparin Side Effects Report #5563498-1
HEPARIN LOCK FLUSH PRESERVATIVE FREE problem was reported by a Pharmacist from UNITED STATES on Dec 14, 2007. Male patient was treated with HEPARIN LOCK FLUSH PRESERVATIVE FREE. After drug was administered, patient experienced the following problems/side effects: serratia bacteraemia, therapeutic product contamination, . HEPARIN LOCK FLUSH PRESERVATIVE FREE dosage: unknown. Patient was hospitalized. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Heparin Side Effects Report #5563499-3
Pharmacist from UNITED STATES reported HEPARIN LOCK FLUSH PRESERVATIVE FREE problem on Dec 14, 2007. Female patient was treated with HEPARIN LOCK FLUSH PRESERVATIVE FREE. After drug was administered, patient experienced the following problems/side effects: serratia bacteraemia, therapeutic product contamination, . HEPARIN LOCK FLUSH PRESERVATIVE FREE dosage: unknown. Patient was hospitalized. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Heparin Side Effects Report #5563500-7
HEPARIN LOCK FLUSH PRESERVATIVE FREE problem was reported by a Pharmacist from UNITED STATES on Dec 14, 2007. Female patient was treated with HEPARIN LOCK FLUSH PRESERVATIVE FREE. After drug was administered, patient experienced the following problems/side effects: serratia bacteraemia, therapeutic product contamination, . HEPARIN LOCK FLUSH PRESERVATIVE FREE dosage: unknown. Patient was hospitalized. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Remicade Side Effects Report #5483451-6
Physician from ITALY reported REMICADE problem on Oct 02, 2007. Male patient was diagnosed with ankylosing spondylitis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: direct infection transmission, hepatitis c, therapeutic product contamination, . REMICADE dosage: unknown. Patient was hospitalized. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Rocaltrol Side Effects Report #5418211-5
ROCALTROL problem was reported by a Health Professional from UNITED STATES on Aug 07, 2007. Male patient, child 3 years of age, weighting 28.66 lb, was diagnosed with hyperparathyroidism and was treated with ROCALTROL. After drug was administered, patient experienced the following problems/side effects: blood parathyroid hormone increased, therapeutic product contamination, . ROCALTROL dosage: unknown. During the same period patient was treated with FERROUS SULPHATE. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Rocaltrol Side Effects Report #5378611-9
Consumer or non-health professional from UNITED STATES reported ROCALTROL problem on June 27, 2007. Male patient, child 3 years of age, was diagnosed with hyperparathyroidism and was treated with ROCALTROL. After drug was administered, patient experienced the following problems/side effects: blood parathyroid hormone increased, therapeutic product contamination, . ROCALTROL dosage: unknown. During the same period patient was treated with FERROUS SULPHATE. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Rocaltrol Side Effects Report #5390212-5
ROCALTROL problem was reported by a Health Professional from UNITED STATES on July 10, 2007. Male patient, child 3 years of age, weighting 28.88 lb, was diagnosed with hyperparathyroidism and was treated with ROCALTROL. After drug was administered, patient experienced the following problems/side effects: blood parathyroid hormone increased, therapeutic product contamination, . ROCALTROL dosage: unknown. During the same period patient was treated with FERROUS SULPHATE. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Rocaltrol Side Effects Report #5378611-9
Consumer or non-health professional from UNITED STATES reported ROCALTROL problem on June 27, 2007. Male patient, child 3 years of age, was diagnosed with hyperparathyroidism and was treated with ROCALTROL. After drug was administered, patient experienced the following problems/side effects: blood parathyroid hormone increased, therapeutic product contamination, . ROCALTROL dosage: unknown. During the same period patient was treated with FERROUS SULPHATE. Patient recovered.
THERAPEUTIC PRODUCT CONTAMINATION : Rocaltrol Side Effects Report #5390212-5
ROCALTROL problem was reported by a Health Professional from UNITED STATES on July 10, 2007. Male patient, child 3 years of age, weighting 28.88 lb, was diagnosed with hyperparathyroidism and was treated with ROCALTROL. After drug was administered, patient experienced the following problems/side effects: blood parathyroid hormone increased, therapeutic product contamination, . ROCALTROL dosage: unknown. During the same period patient was treated with FERROUS SULPHATE. Patient recovered.